Teva Pharmaceutical Industries | TEVA - Ebit

Stock Price
9,270.00
Daily Change
71.00 0.77%
Monthly
-0.18%
Yearly
71.70%
Q2 Forecast
8,997.46

Teva Pharmaceutical Industries reported $577M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Aspen Pharmacare ZAR 3.76B 1.04B Dec/2025
Cipla INR 9.77B 6.21B Dec/2025
Dr.Reddys Laboratories INR 13.94B 1.79B Dec/2025
Guangzhou Baiy CNY -661.07M 1.74B Dec/2025
Jiangsu Hengrui CNY 2.56B 302M Mar/2026
Kalbe Farma IDR 851.77B 342.14B Sep/2025
Richter Gedeon HUF 63.58B 6.08B Sep/2025
Sh Fosun Pharma CNY 864.14M 185.2M Dec/2025
Sun Pharmaceuticals INR 40.62B 6.95B Dec/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025